Vaxxa AB (NGM:VAXXA)
Sweden · Delayed Price · Currency is SEK 0.5060
-0.0380 (-6.99%)
At close: May 11, 2026
Vaxxa AB Revenue
Vaxxa AB had revenue of 18.49M SEK in the quarter ending March 31, 2026, with 44.45% growth. This brings the company's revenue in the last twelve months to 83.00M, up 8.92% year-over-year. In the year 2025, Vaxxa AB had annual revenue of 77.45M, down -8.01%.
Revenue (ttm)
83.00M
Revenue Growth
+8.92%
P/S Ratio
0.26
Revenue / Employee
9.22M
Employees
9
Market Cap
21.94M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 77.45M | -6.74M | -8.01% |
| Dec 31, 2024 | 84.19M | 30.61M | 57.14% |
| Dec 31, 2023 | 53.58M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 4.75M | 4.15M | 690.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Goobit Group AB | 240.28M |
| Relevance Communication Nordic AB | 38.85M |
| Level Bio AB | 33.51M |
| Qbrick AB | 31.41M |
| edyoutec AB | 17.05M |
| Kvix AB | 12.79M |
| Nattaro Labs AB | 6.04M |
| Attana AB | 4.01M |